Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | ||||
Skin exfoliation | Localized exfoliation | very common | x | x | x | ||||
Application site erythema | Application site erythema | very common | x | ||||||
Pruritus | Pruritus | common | x | ||||||
Sensitisation | Sensitisation | common | x | x | x | ||||
Burning sensation | Burning sensation | uncommon | x | ||||||
Anaphylactic shock | Anaphylactic shock | rare | x | ||||||
Hypersensitivity | Hypersensitivity | rare | x | ||||||
Pain | Pain | rare | x | ||||||
Skin irritation | Skin irritation | rare | x | x | |||||
Application site rash | Application site rash | rare | x | ||||||
Application site discolouration | Application site discolouration | rare | x | ||||||
Application site hypersensitivity | Application site hypersensitivity | rare | x | ||||||
Oedema | Oedema | x | |||||||
Immune system disorder | Immune system disorder | x | |||||||
Erythema | Erythema | x | x | ||||||
Dermatitis contact | Allergic contact dermatitis | x | x | ||||||
Skin disorder | Unspecified disorder of skin and subcutaneous tissue | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||
---|---|---|---|---|---|---|---|---|---|
Acne vulgaris | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |